Читать книгу Autoimmune Liver Disease - Группа авторов - Страница 10

Contributors

Оглавление

Eleanor Barnes PhD, FRCP, F Med Sci Professor of Hepatology and Experimental Medicine, Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford; and Oxford NIHR Biomedical Research Centre, Oxford, UK

Kirsten Muri Boberg MD, PhD Professor Norwegian PSC Research Center and Section for Gastroenterology, Department of Transplantation Medicine, Division of Surgery, Inflammatory Medicine and Transplantation, Oslo University Hospital Rikshospitalet; and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

Marco Carbone MD, PhD Clinical Lecturer in Gastroenterology, Program for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milan Bicocca, Milan, Italy

Olivier Chazouillères MD Director Department of Hepatology, AP‐HP, Hôpital Saint‐Antoine, Service d’Hépatologie; Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis; INSERM, UMR‐S 938, CDR Saint‐Antoine; and Sorbonne Université, Paris, France

Emma L. Culver PhD, MRCP Consultant Hepatologist and Senior Lecturer, Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford; and Oxford NIHR Biomedical Research Centre, Oxford, UK

M. Eric Gershwin MD, MACR, MACP Distinguished Professor of Medicine, Chief, Division of Rheumatology, Allergy and Clinical Immunology, The Jack and Donald Endowed Professor, University of California School of Medicine, Davis, California, USA

Alessio Gerussi MD Research Fellow, Division of Gastroenterology, University of Milan Bicocca, Milan, Italy

Núria Guañabens MD Professor of Medicine, University of Barcelona; and Senior Consultant Physician, Department of Rheumatology, Metabolic Bone Diseases Unit, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain

Aliya Gulamhusein MD, MPH Toronto Centre for Liver Diseases, Toronto General Hospital, University Health Network; and Division of Gastroenterology, University of Toronto, Toronto, Ontario, Canada

Peter C. Hayes MBChB, BMSc, MD, PhD Head of Department, Professor of Medicine and Consultant Physician, Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK

Michael A. Heneghan MD, MMedSc, FRCPI Clinical Director for Liver Services and Consultant Hepatologist and Professor of Hepatology, Institute of Liver Studies, King's College Hospital, Denmark Hill, London, UK

David Jones MD, PhD, OBE Dean for the NIHR Academy, Professor of Liver Immunology, Newcastle University; and Honorary Consultant Hepatologist, Newcastle upon Tyne Hospitals, Newcastle upon Tyne, UK

Patrick S.C. Leung PhD Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan

Ying Qi (Tammy) Li BSc Division of Gastroenterology and Hepatology, University of Alberta, Edmonton, Alberta, Canada

Andrew L. Mason MBBS, FRCPI, FAASLD Professor of Medicine, and Director of the Applied Genomic Core, Division of Gastroenterology and Hepatology, University of Alberta, Edmonton, Alberta, Canada

Patrick McKiernan MD Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

George F. Mells PhD, MRCP Senior Lecturer, Division of Gastroenterology and Hepatology, Department of Medicine, and Academic Department of Medical Genetics, University of Cambridge, Cambridge, UK

Giorgina Mieli‐Vergani MD, PhD, FRCP, FRCPCH, FAASLD Emeritus Professor of Paediatric Hepatology, Honorary Consultant Paediatric Liver, GI & Nutrition Centre, Mowat Labs, King’s College London Faculty of Life Sciences and Medicine at King’s College Hospital, Denmark Hill, London, UK

Piotr Milkiewicz MD, DSc, MRCP(UK) Professor of Medicine/Consultant Physician, Head, Liver and Internal Medicine Unit, Medical University of Warsaw, Warsaw, Poland

Carlos Moctezuma‐Velázquez MD Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA Division of Gastroenterology and Liver Unit, University of Alberta Hospital, Edmonton, Alberta, Canada

Aldo J. Montano‐Loza MD, PhD Division of Gastroenterology and Liver Unit, University of Alberta Hospital, Edmonton, Alberta, Canada

Albert Parés MD Professor of Medicine, University of Barcelona; and Senior Consultant Physician, Liver Unit, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain

Marcus C. Robertson MD, PhD, FRACP Gastroenterologist and Hepatologist, Monash Health, Melbourne; and Adjunct Senior Lecturer, Monash University Department of Medicine, Clayton, Australia

Isaiah G. Roepe BS Medical Student, Baylor College of Medicine, Houston, Texas, USA

Mario Strazzabosco MD, PhD Professor of Medicine; Clinical Program Leader, Liver Cancer Program; and Deputy Director, Yale Liver Center, Digestive Disease Section, Yale Liver Center, Yale University School of Medicine, New Haven, Connecticut, USA

Atsushi Tanaka MD Associate Professor, Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan

Benedetta Terziroli Beretta‐Piccoli MD Epatocentro Ticino, Via Soldino 5, 6900 Lugano, Switzerland Institute of Liver Studies, Mowat Labs, King's College Hospital, Denmark Hill, London, UK

Eleni Theocharidou MSc, PhD Senior Clinical Fellow, Institute of Liver Studies, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Diego Vergani MD, PhD, FRCP, FRCPath, FAASLD Emeritus Professor of Liver Immunopathology, Honorary Consultant, Institute of Liver Studies, Mowat Labs, King’s College London Faculty of Life Sciences and Medicine at King’s College Hospital, Denmark Hill, London, UK

Mette Vesterhus MD, PhD Consultant Physician, Norwegian PSC Research Center, Department of Transplantation Medicine, Division of Surgery, Inflammatory Medicine and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo; and Department of Clinical Science, University of Bergen, Bergen, Norway

John M. Vierling MD, FACP, FAASLD, AGAF Professor of Medicine and Surgery, Chief of Hepatology, Director of Baylor Liver Health, Director of Advanced Liver Therapies, Program Director, Hepatology and Liver Transplantation Fellowship Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Section of Gastroenterology and Hepatology, Margaret M. and Albert B. Alkek Department of Medicine, Baylor College of Medicine, Houston, Texas, USA

Ewa Wunsch MD Translational Medicine Group, Pomeranian Medical University, Szczecin, Poland

Autoimmune Liver Disease

Подняться наверх